HK Stock MarketDetailed Quotes

CONSUN PHARMA (01681)

Watchlist
  • 17.260
  • +0.250+1.47%
Market Closed Jan 16 16:01 CST
14.65BMarket Cap13.25P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

CONSUN PHARMA (01681) Income Statement

All
YOY yoy
Hide blank lines yoy
(Q6)Jun 30, 2025
(FY)Dec 31, 2024
(Q6)Jun 30, 2024
(FY)Dec 31, 2023
(Q6)Jun 30, 2023
(FY)Dec 31, 2022
(Q6)Jun 30, 2022
(FY)Dec 31, 2021
(Q6)Jun 30, 2021
(FY)Dec 31, 2020
Turnover
23.65%1.57B
14.56%2.97B
13.30%1.27B
10.71%2.59B
12.70%1.12B
14.43%2.34B
12.07%993.53M
16.65%2.04B
15.76%886.53M
1.42%1.75B
Operating income
23.65%1.57B
14.56%2.97B
13.30%1.27B
10.71%2.59B
12.70%1.12B
14.43%2.34B
12.07%993.53M
16.65%2.04B
15.76%886.53M
1.42%1.75B
Cost of sales
-12.11%-359.91M
-8.48%-725.13M
-13.33%-321.03M
-15.90%-668.44M
-10.89%-283.26M
-11.48%-576.74M
-13.38%-255.44M
-19.98%-517.32M
-15.97%-225.29M
7.65%-431.16M
Operating expenses
-12.11%-359.91M
-8.48%-725.13M
-13.33%-321.03M
-15.90%-668.44M
-10.89%-283.26M
-11.48%-576.74M
-13.38%-255.44M
-19.98%-517.32M
-15.97%-225.29M
7.65%-431.16M
Gross profit
27.56%1.21B
16.67%2.24B
13.28%947.52M
9.01%1.92B
13.32%836.42M
15.42%1.76B
11.62%738.09M
15.56%1.53B
15.68%661.24M
4.78%1.32B
Selling expenses
-25.18%-515.65M
-15.18%-981.58M
-13.78%-411.91M
-10.40%-852.21M
-10.57%-362.03M
-24.50%-771.96M
-18.28%-327.42M
-14.20%-620.04M
-23.55%-276.81M
-0.69%-542.93M
Administrative expenses
-31.82%-177.57M
1.18%-311.87M
1.49%-134.71M
2.14%-315.6M
-1.07%-136.74M
-15.20%-322.5M
-31.87%-135.3M
-37.86%-279.96M
-16.87%-102.6M
-25.75%-203.07M
Impairment and provision
-106.62%-607K
-30.31%8.78M
-47.69%9.17M
-61.23%12.6M
37.08%17.53M
80.09%32.49M
850.22%12.79M
161.45%18.04M
109.28%1.35M
92.59%-29.36M
-Other impairment is provision
-106.62%-607K
-30.31%8.78M
-47.69%9.17M
-61.23%12.6M
37.08%17.53M
80.09%32.49M
850.22%12.79M
161.45%18.04M
109.28%1.35M
58.26%-29.36M
Special items of operating profit
-36.62%23.62M
-26.05%87.63M
25.74%37.26M
110.16%118.5M
16.44%29.63M
-11.04%56.39M
-14.47%25.45M
7.75%63.38M
144.70%29.76M
3,954.91%58.83M
Operating profit
20.37%538.47M
18.09%1.05B
16.25%447.33M
16.85%884.97M
22.70%384.81M
6.85%757.33M
0.22%313.61M
17.12%708.77M
21.57%312.93M
271.92%605.14M
Financing cost
81.55%-2.47M
-17.04%-24.89M
-85.58%-13.38M
-94.49%-21.26M
-76.04%-7.21M
15.28%-10.93M
21.89%-4.09M
39.70%-12.91M
54.40%-5.24M
26.31%-21.4M
Share of profits of associates
---763K
---66K
----
----
----
----
----
----
----
----
Earning before tax
23.34%535.24M
18.11%1.02B
14.92%433.96M
15.72%863.7M
22.00%377.61M
7.26%746.39M
0.59%309.52M
19.21%695.86M
25.12%307.69M
336.72%583.74M
Tax
1.85%-32.39M
-33.16%-102.73M
-10.82%-33M
-23.05%-77.15M
-114.56%-29.78M
42.35%-62.7M
77.90%-13.88M
-6.62%-108.74M
-28.91%-62.79M
-44.59%-101.99M
After-tax profit from continuing operations
25.41%502.85M
16.63%917.37M
15.27%400.96M
15.04%786.55M
17.65%347.83M
16.45%683.7M
20.72%295.64M
21.87%587.12M
24.18%244.91M
663.19%481.74M
Earning after tax
25.41%502.85M
16.63%917.37M
15.27%400.96M
15.04%786.55M
17.65%347.83M
16.45%683.7M
20.72%295.64M
21.87%587.12M
24.18%244.91M
663.19%481.74M
Minority profit
280.75%4.55M
242.38%6.92M
1,967.19%1.2M
155.70%2.02M
94.12%-64K
125.86%790K
81.02%-1.09M
82.08%-3.06M
50.84%-5.74M
-2.08%-17.05M
Profit attributable to shareholders
24.65%498.3M
16.05%910.46M
14.91%399.77M
14.88%784.53M
17.24%347.89M
15.71%682.91M
18.39%296.73M
18.32%590.17M
19.99%250.64M
524.89%498.79M
Basic earnings per share
18.00%0.59
12.12%1.11
13.43%0.5
15.12%0.99
17.77%0.4408
16.22%0.86
19.51%0.3743
21.31%0.74
23.94%0.3132
577.78%0.61
Diluted earnings per share
18.37%0.58
11.22%1.09
12.21%0.49
13.95%0.98
16.98%0.4367
17.81%0.86
19.76%0.3733
19.67%0.73
23.35%0.3117
577.78%0.61
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
Audit Opinions
--
Unqualified Opinion
--
Unqualified Opinion
--
Unqualified Opinion
--
Unqualified Opinion
--
Unqualified Opinion
Auditor
--
KPMG
--
KPMG
--
KPMG
--
KPMG
--
KPMG
(Q6)Jun 30, 2025(FY)Dec 31, 2024(Q6)Jun 30, 2024(FY)Dec 31, 2023(Q6)Jun 30, 2023(FY)Dec 31, 2022(Q6)Jun 30, 2022(FY)Dec 31, 2021(Q6)Jun 30, 2021(FY)Dec 31, 2020
Turnover 23.65%1.57B14.56%2.97B13.30%1.27B10.71%2.59B12.70%1.12B14.43%2.34B12.07%993.53M16.65%2.04B15.76%886.53M1.42%1.75B
Operating income 23.65%1.57B14.56%2.97B13.30%1.27B10.71%2.59B12.70%1.12B14.43%2.34B12.07%993.53M16.65%2.04B15.76%886.53M1.42%1.75B
Cost of sales -12.11%-359.91M-8.48%-725.13M-13.33%-321.03M-15.90%-668.44M-10.89%-283.26M-11.48%-576.74M-13.38%-255.44M-19.98%-517.32M-15.97%-225.29M7.65%-431.16M
Operating expenses -12.11%-359.91M-8.48%-725.13M-13.33%-321.03M-15.90%-668.44M-10.89%-283.26M-11.48%-576.74M-13.38%-255.44M-19.98%-517.32M-15.97%-225.29M7.65%-431.16M
Gross profit 27.56%1.21B16.67%2.24B13.28%947.52M9.01%1.92B13.32%836.42M15.42%1.76B11.62%738.09M15.56%1.53B15.68%661.24M4.78%1.32B
Selling expenses -25.18%-515.65M-15.18%-981.58M-13.78%-411.91M-10.40%-852.21M-10.57%-362.03M-24.50%-771.96M-18.28%-327.42M-14.20%-620.04M-23.55%-276.81M-0.69%-542.93M
Administrative expenses -31.82%-177.57M1.18%-311.87M1.49%-134.71M2.14%-315.6M-1.07%-136.74M-15.20%-322.5M-31.87%-135.3M-37.86%-279.96M-16.87%-102.6M-25.75%-203.07M
Impairment and provision -106.62%-607K-30.31%8.78M-47.69%9.17M-61.23%12.6M37.08%17.53M80.09%32.49M850.22%12.79M161.45%18.04M109.28%1.35M92.59%-29.36M
-Other impairment is provision -106.62%-607K-30.31%8.78M-47.69%9.17M-61.23%12.6M37.08%17.53M80.09%32.49M850.22%12.79M161.45%18.04M109.28%1.35M58.26%-29.36M
Special items of operating profit -36.62%23.62M-26.05%87.63M25.74%37.26M110.16%118.5M16.44%29.63M-11.04%56.39M-14.47%25.45M7.75%63.38M144.70%29.76M3,954.91%58.83M
Operating profit 20.37%538.47M18.09%1.05B16.25%447.33M16.85%884.97M22.70%384.81M6.85%757.33M0.22%313.61M17.12%708.77M21.57%312.93M271.92%605.14M
Financing cost 81.55%-2.47M-17.04%-24.89M-85.58%-13.38M-94.49%-21.26M-76.04%-7.21M15.28%-10.93M21.89%-4.09M39.70%-12.91M54.40%-5.24M26.31%-21.4M
Share of profits of associates ---763K---66K--------------------------------
Earning before tax 23.34%535.24M18.11%1.02B14.92%433.96M15.72%863.7M22.00%377.61M7.26%746.39M0.59%309.52M19.21%695.86M25.12%307.69M336.72%583.74M
Tax 1.85%-32.39M-33.16%-102.73M-10.82%-33M-23.05%-77.15M-114.56%-29.78M42.35%-62.7M77.90%-13.88M-6.62%-108.74M-28.91%-62.79M-44.59%-101.99M
After-tax profit from continuing operations 25.41%502.85M16.63%917.37M15.27%400.96M15.04%786.55M17.65%347.83M16.45%683.7M20.72%295.64M21.87%587.12M24.18%244.91M663.19%481.74M
Earning after tax 25.41%502.85M16.63%917.37M15.27%400.96M15.04%786.55M17.65%347.83M16.45%683.7M20.72%295.64M21.87%587.12M24.18%244.91M663.19%481.74M
Minority profit 280.75%4.55M242.38%6.92M1,967.19%1.2M155.70%2.02M94.12%-64K125.86%790K81.02%-1.09M82.08%-3.06M50.84%-5.74M-2.08%-17.05M
Profit attributable to shareholders 24.65%498.3M16.05%910.46M14.91%399.77M14.88%784.53M17.24%347.89M15.71%682.91M18.39%296.73M18.32%590.17M19.99%250.64M524.89%498.79M
Basic earnings per share 18.00%0.5912.12%1.1113.43%0.515.12%0.9917.77%0.440816.22%0.8619.51%0.374321.31%0.7423.94%0.3132577.78%0.61
Diluted earnings per share 18.37%0.5811.22%1.0912.21%0.4913.95%0.9816.98%0.436717.81%0.8619.76%0.373319.67%0.7323.35%0.3117577.78%0.61
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards HKASHKASHKASHKASHKASHKASHKASHKASHKASHKAS
Audit Opinions --Unqualified Opinion--Unqualified Opinion--Unqualified Opinion--Unqualified Opinion--Unqualified Opinion
Auditor --KPMG--KPMG--KPMG--KPMG--KPMG

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Market Insights
HK Tech and Internet Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +17.85%
Sample Name
Sample Code
 +16.38%
Sample Name
Sample Code
 +13.45%
4
BIDU-SW
09888
+5.97%
5
JD HEALTH
06618
+5.25%
View More
New Consumption Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +11.88%
Sample Name
Sample Code
 +6.48%
Sample Name
Sample Code
 +4.52%
4
GIANT BIOGENE
02367
+4.07%
5
BLOKS
00325
+2.72%
View More
Hong Kong stocks continue to recover! The Hang Seng Index briefly returned to 26,000 points.
Recently, Hong Kong stocks have rebounded from their lows, with the three major indices continuing their upward momentum. The Hang Seng Inde Show More
Are you foolish? What's the point of knowing your mistakes?
[Opportunity Express] With stock prices soaring, should SMIC "take profits and exit" or "patiently hold on"?

- No more -